Average Co-Inventor Count = 5.63
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Adimab, LLC (7 from 48 patents)
2. Merrimack Pharmaceuticals, Inc. (6 from 52 patents)
3. Genentech, Inc. (3 from 3,222 patents)
4. Mersana Therapeutics, Inc. (3 from 36 patents)
5. Massachusetts Institute of Technology (2 from 8,373 patents)
6. The University of Texas System (2 from 5,450 patents)
20 patents:
1. 12258679 - Polyclonal mixtures of antibodies, and methods of making and using them
2. 12187799 - Dual specificity antibodies to PD-L1 and PD-L2 and methods of use therefor
3. 12134648 - Dual specificity antibodies to human PD-L1 and PD-L2 and methods of use therefor
4. 11746160 - Antibodies against BACE1 and use thereof for neural disease immunotherapy
5. 11542330 - Anti-CD3-binding domains and antibodies comprising them, and methods for their generation and use
6. 11518812 - Monoclonal antibodies against HER2 epitope and methods of use thereof
7. 11390964 - Polyclonal mixtures of antibodies, and methods of making and using them
8. 11008403 - Anti-transferrin receptor / anti-BACE1 multispecific antibodies and methods of use
9. 10882920 - Antibodies against BACE1 and use thereof for neural disease immunotherapy
10. 10684289 - Polyclonal mixtures of antibodies, and methods of making and using them
11. 10072299 - Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
12. 9902999 - Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
13. 9885087 - Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
14. 9738720 - Monoclonal antibodies against HER2 epitope and methods of use thereof
15. 9555112 - Monoclonal antibodies against HER2 epitope and methods of use thereof